Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review

Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review

Clinical research in high-income countries is increasingly demonstrating the cost- effectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of adverse drug reactions and improving overall patient care. Medications are prescribed based on an individual’s genotype (pharmacogen...

Full description

Bibliographic Details
Main Authors: Emiliene B. Tata, Melvin A. Ambele, Michael S. Pepper
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Pharmaceutics
Subjects:
clinical pharmacogenetics
pharmacogenetic testing
adverse drug reactions
genotype
phenotype
pharmacogene
Online Access:https://www.mdpi.com/1999-4923/12/9/809

Similar Items

Similar Items